Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Huntington's disease (HD) is an inherited neurodegenerative disorder with significant peripheral effects impacting patient quality of life.
• Circulating microRNAs (cmiRNAs) are key regulators of gene expression and intercellular communication, offering insights into neuronal-peripheral tissue crosstalk.

Purpose of the Study:

• To investigate the circulating microRNA (cmiRNA) profile in plasma of symptomatic Huntington's disease (HD) patients.
• To identify potential cmiRNA biomarkers associated with HD progression and patient stratification.

Main Methods:

• Plasma samples from 15 symptomatic HD patients (40-45 CAG repeats) and 7 healthy controls were analyzed.
• miRNAs were isolated and profiled using human miRNome panels (752 mature miRNAs).
• Statistical analysis, including Bonferroni's correction, was applied to identify significant alterations.

Main Results:

• 168 cmiRNAs were found to be altered in symptomatic HD patients compared to controls.
• Specific miRNAs (e.g., miR-877-5p, miR-223-3p) were significantly increased in HD patients.
• Disease progression correlated with altered levels of other miRNAs (e.g., miR-122-5p, miR-100-5p).

Conclusions:

• Circulating microRNA profiles in HD patients are significantly altered and may reflect disease progression.
• Identified cmiRNAs show potential as diagnostic and monitoring biomarkers for Huntington's disease.
• cmiRNA profiling may facilitate personalized therapeutic strategies targeting specific metabolic pathways in HD.